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Abstract
Background: Angiogenesis is a crucial process in follicular development and luteogenesis. The
nerve growth factor (NGF) promotes angiogenesis in various tissues. An impaired production of
this neurotrophin has been associated with delayed wound healing. A variety of ovarian functions
are regulated by NGF, but its effects on ovarian angiogenesis remain unknown. The aim of this
study was to elucidate if NGF modulates 1) the amount of follicular blood vessels and 2) ovarian
expression of two angiogenic factors: vascular endothelial growth factor (VEGF) and transforming
growth factor beta 1 (TGFbeta1), in the rat ovary.
Results: In cultured neonatal rat ovaries, NGF increased VEGF mRNA and protein levels, whereas
TGFbeta1 expression did not change. Sectioning of the superior ovarian nerve, which increases
ovarian NGF protein content, augmented VEGF immunoreactivity and the area of capillary vessels
in ovaries of prepubertal rats compared to control ovaries.
Conclusion: Results indicate that NGF may be important in the maintenance of the follicular and
luteal vasculature in adult rodents, either indirectly, by increasing the expression of VEGF in the
ovary, or directly via promoting the proliferation of vascular cells. This data suggests that a
disruption on NGF regulation could be a component in ovarian disorders related with impaired
angiogenesis.
Background
Angiogenesis is an essential process in follicular develop-
ment and luteogenesis [1,2]. Once the proliferation of
new blood vessels is complete, a rapid capillary regression
takes place in the non-fertile cycle which suggests a deli-
cate coordination between angiogenesis inducers and
inhibitors [3]. The intervention of ovarian vascularization
has an adverse effect on the growth of the dominant folli-
cle, the ovulation and the functioning of the corpus
luteum and its ability to secrete progesterone [1,4].
The regulation of cyclic angiogenesis in the ovary is com-
manded by a variety of growth factors; vascular endothe-
lial growth factor (VEGF) playing a major role by
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stimulating vessel hyperpermeability, endothelial cell
proliferation and migration [5]. Several splicing isoforms
are generated from VEGF gene, and the proteins reach
endothelial cells either by difussion of the shorter iso-
forms (VEGF 121, VEGF 165) or following proteolitic
cleavage of longer ones (VEGF 189, VEGF 206) [3]. The
mRNAs for the isoforms of 121 and 165 aminoacids are
dominant in normal human ovaries [5]. In rodents, VEGF
isoforms are one aminoacid shorter than in human, and
have a similar distribution and function [6,7]. Another
molecule that modulates angiogenesis is the transforming
growth factor beta 1 (TGFβ1), being essential for matrix
remodeling, vessel stabilization and pericyte differentia-
tion. TGFβ1 deficient mice have impaired vessel wall
integrity [8,9]. In the human ovary, follicular cells express
TGFβ1, which has proliferative and differentiation effects
on granulosa cells [10,11]. It also increases the size of fol-
licles from adult mice [12]. In the hamster ovary, the
mRNAs for TGFβ receptors are cyclically regulated by
gonadotropins and ovarian steroids, increasing their lev-
els as the follicle develops during the estral cycle [13].
Another important growth factor involved in ovarian
physiology is the nerve growth factor (NGF). Mammalian
ovary expresses the neurotrophin and both the high- and
the low-affinity receptor for NGF (trkA and p75, respec-
tively) [14-16]. In neonatal rat ovaries, the expression of
follicular stimulating hormone (FSH) receptors is induced
by NGF [17]. Immunoneutralization of NGF during early
postnatal life of the rat results in undersized antral folli-
cles, delayed puberty and disrupted estrous cyclicity [18].
TrkA and NGF are transiently expressed in preovulatory
follicles in the first preovulatory surge of gonadotropins at
puberty in the rat. The use of a neutralizing antibody to
NGF or pharmacological blockade of trkA tyrosine kinase
activity targeted to one ovary resulted in the ipsilateral
inhibition of ovulation [19].
Although NGF promotes angiogenesis and/or induces the
expression of angiogenic molecules in several tissues, such
as skin, muscle, cornea, arteries [20-23] and the immu-
noneutralization of this neurotrophin delays the repara-
tive neovascularization of lesions in the mice [21], the
effects of NGF on ovarian angiogenesis remain unex-
plored. This study investigates the role of NGF in regulat-
ing the expression of the angiogenic factors VEGF and
TGFβ1, and the area of blood vessels in the rat ovary.
Gonadotropins can upregulate different angiogenesis-
related parameters in the ovary [24-26]; hence, to avoid
this influence, we selected early stages of rat ovarian life as
a model, when the tissue has not become gonadotropin-
dependent [27].
Methods
Animals
Sprague Dawley rats obtained from the Faculty of Chemi-
cal and Pharmaceutical Sciences, Universidad de Chile
were housed under controlled conditions of temperature
(21°C) and light (12 h of light, 12 h of darkness; lights on
from 0800–2000 h). Food and drinking water were pro-
vided ad libitum. All the protocols for animal care and use
included in this study were approved by the institutional
review board of the Faculty of Chemical and Pharmaceu-
tical Sciences, Universidad de Chile.
Organ culture
Ovaries from 2 day old rats were dissected under aseptic
conditions, placed on sterile lens paper, and cultured on
plastic supports at the interface of air/culture medium
[28], under an atmosphere of 5% CO2. For histochemical
studies, one ovary per well was utilized, and for mRNA
studies, three glands per well were cultured. Considering
this, for an n = 5, 20 pups were utilized for each incuba-
tion point. Ovaries were cultured in 24-well plates (Bec-
ton Dickinson, USA); each well contained 1 ml DMEM: F-
12 (50% vol/vol, Sigma Chemicals, St Louis, MO, USA)
medium supplemented with sodium bicarbonate (600
mg/l, Sigma Chemicals, St Louis, MO, USA), penicillin
(50 mg/l, Laboratorio Chile, Santiago, Chile), gentamycin
(80 mg/l, Andrómaco, Santiago, Chile), streptomycin (50
mg/l, Laboratorio Chile, Santiago, Chile) and ketocona-
zol (5 mg/l, Laboratorio Chile, Santiago, Chile). The ova-
ries were stimulated with NGF 100 ng/ml (Sigma
Chemicals, St Louis, MO, USA). The optimal dose of NGF
was established by previous studies from our group [17].
The contralateral ovaries cultured with medium alone
were used as controls. The times of culture were 2, 4, 8 and
24 h. In the case of mRNA studies, the ovaries were col-
lected and stored at -80°C until RNA extraction. The ova-
ries collected for immunohistochemistry were fixed in
Bouin's fixative.
Ovary denervation
We used 16 prepuberal rats of 23–24 day old (body
weight 60 g aprox.). They were anaesthetized with isoflu-
rane 1% v/v, 2.5 l/min (Baxter Healthcare Co, Guayama,
Puerto Rico). The dissection of the superior ovarian nerve
(SON) was performed in both ovaries under aseptic con-
ditions through a single dorsal midline incision. This pro-
cedure has shown to induce an increase of NGF within the
gland [29]. Because denervation induces hypertrophy of
the contralateral ovary [30], controls consisted in different
animals submitted to a simulated operation. The ovaries
were collected three days later (from a total of 6 rats; 3
controls and 3 denervated) or six days later (from a total
of 10 rats; 5 controls and 5 denervated), and stored at -
80°C for mRNA studies, or fixed in Bouin's fixative for
histochemical procedures. The time for ovary harvestingReproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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after denervation was established by previous studies
from our group [29].
Immunohistochemistry
Immunohistochemical detection of VEGF and TGFβ1 in
denervated ovaries and cultured tissues was performed as
follows: the ovaries were fixed by immersion in Bouin's
fixative, embedded in paraffin, serially sectioned at 4 μm
and processed for immunohistochemistry using polyclo-
nal antibodies from Santa Cruz Biotechnology (anti-VEGF
[C-1], sc-7269 and anti-TGFβ1 [V] sc-146, both in a 1:50
dilution). Tissue sections were incubated overnight at 4°C
with the antibody and the immunoreaction was devel-
oped the next day using the NBT-BCIP procedure (Sigma
Chemicals, St Louis, MO, USA) for VEGF in neonatal rat
ovaries, or the DAB procedure (LabVision Co, Freemont
CA, USA) for the rest of the detections. Controls consist-
ent of adjacent sections incubated without the primary
antibody, or sections incubated with the antibody preab-
sorbed with the corresponding ligand showed no stain-
ing, proving the specificity of the immunoreaction.
Whenever a well defined mark was obtained, cell count-
ing was performed by three independent observers and
the data were expressed as H-Score. The H-Score is the
sum of the proportion of cells showing different degrees
of reactivity, and was calculated as follows: 0 times the %
of negative cells + 1 time the % of weakly positive cells +
2 times the % of moderately positive cells + 3 times the %
of strongly positive cells. The H-Score ranges from 0–300,
being the maximum score representative of a 100% of
cells with strong positivity [31]. In the case of diffuse
mark, staining intensity was evaluated with an automated
digitizing system (UN-SCAN-IT gel 4.1, Silk Scientific Co,
USA) and the data were expressed as number of pixels.
Immunohistochemical detection of endothelial cell
marker PECAM-1 in denervated ovaries was performed
using an antibody from Santa Cruz Biotechnology (anti-
PECAM-1 [M-20] in a 1:100 dilution). Tissue sections
were incubated with the antibody overnight at 4°C and
the immunoreaction was developed the next day using
the DAB procedure (LabVision Co, Freemont CA, USA).
Controls consisted of adjacent sections incubated without
the primary antibody. The area of positive staining was
evaluated with an automated system (Image J 1.36b, NIH,
USA) and the data were expressed as % area of the ovary
section.
RNA extraction and reverse transcription reaction
Total RNA was extracted from rat ovaries using guanidine
isothiocyanate and phenol-chloroform extraction (Trizol
Reagent, Invitrogen, Foster City CA, USA) following the
manufacturer's protocol. Concentration and purity of
RNA were measured using a spectrophotometer at 260
and 280 nm. First strand cDNA was synthesized in a 20 ml
reaction mixture using 1 μg of total RNA. The reaction
tubes contained 0.5 μl random hexamers (500 ng/μl, Inv-
itrogen, Foster City CA, USA), 1 μl dNTPs (10 mM, Invit-
rogen, Foster City CA, USA), 4 μl 5× reaction buffer (250
mM Tris-HCl pH 8.3, 375 mM KCl, 15 mM MgCl2, Invit-
rogen, Foster City CA, USA), 2 μl DTT (0.1 M, Invitrogen,
Foster City CA, USA), 1 μl ribonuclease inhibitor (10 U/
μl, Invitrogen, Foster City CA, USA) and 1 μl M-MLV
reverse transcriptase (200 U/μl, Invitrogen, Foster City
CA, USA). Reactions were incubated at 37°C for 60 min-
utes and inactivated by freezing.
Polymerase chain reaction
The specific primer sequences for the examined genes and
the predicted PCR product sizes are shown in Table 1. The
cDNA was amplified in a 25 μl reaction mixture using 1 μl
of single-strand cDNA. PCR conditions were as follows:
2.5 μl 10 × reaction buffer (200 mM Tris-HCl pH 8.4, 500
mM KCl, Biotools, Madrid, Spain), 1 μl MgCl2 (50 mM),
0.5 μl dNTPs (10 mM each), 1.25 μl each primer (10 μM,
Polyscience, Santiago, Chile), 0.15 μl DNA polymerase (5
U/μl, Biotools, Madrid, Spain). Reaction mixtures were
incubated in a thermal cycler (Eppendorf, Foster City CA,
USA) for 2 minutes at 94°C. Then 23, 27, or 28 cycles
were performed for cyclophilin, VEGF and TGFβ1 respec-
tively including: denaturation at 94°C for 45 seconds,
annealing at 62°C for 1 minute and extension at 72°C for
1 minute. The optimal number of cycles was experimen-
tally determined by analyzing the exponential phase of
amplification reaction (data not shown). The PCR prod-
ucts were separated on Tris-borate-EDTA 2% agarose gels
containing 200 ng/ml ethidium bromide (Invitrogen,
Foster City CA, USA). DNA size markers were run in par-
allel to validate the predicted sizes of the amplified bands
(100-bp DNA ladder, Biotools, Madrid, Spain). The gels
were visualized under UV light, photographed using a
capturing program (Ultra Violet Products Doc-It), and
analyzed with an automated digitizing system (UN-
SCAN-IT gel 4.1, Silk Scientific Corporation, Orem UT,
USA). Differences between the experimental versus con-
trol conditions, were obtained by the ratio of the intensity
between specific gene and constitutive gene of each sam-
ple, determined by densitometry.
Statistical analysis
The differences in mRNA levels, immunoreactivity and
area of positive staining were analyzed using Mann Whit-
ney test.
Results
NGF increases VEGF mRNA and protein levels in neonatal 
rat ovaries
The photograph of 2% agarose gel electrophoresis of rep-
resentative PCR products for VEGF120, VEGF164, TGFβ1
and Cyclophilin (as constitutive gene) are shown in figureReproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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1A-C. The exponential phase of amplification for each tar-
get sequence was determined by performing PCR under
different number of cycles (ranging from 20 to 35 cycles).
The PCR products were separated in agarose gels, stained
with ethidium bromide, and the intensity of the bands
was analyzed with an automated digitalizing program
(UN-SCAN-IT gel 4.1, Silk Scientific Corporation, Orem
UT, USA). Results were plotted to visualize the exponen-
tial region of the curve, and thus the optimal number of
cycles was selected for each target sequence (not shown).
A dose/response curve was performed for each target
sequence by adding increasing amounts of cDNA to the
respective PCR mix. The response showed to be linear
under working conditions (see figure 1D-F).
Neonatal rat ovaries were cultured with NGF (100 ng/ml)
for 2, 4, 8 and 24 h. The mRNA levels for VEGF 120 and
VEGF 164 – the most relevant VEGF isoforms in ovarian
physiology – exhibited a significant increase in NGF-stim-
ulated tissues compared to controls, in the two-hour cul-
ture, as shown in figure 2. No change on TGFβ1 mRNA
content was found at any assayed stimulation time.
Regarding localization of VEGF protein in neonatal rat
ovaries, although two controls for specificity were used,
immunoreactivity was present more specifically in granu-
losa cell layer of primary follicles (figures 3A and 3B) and
also in other types of ovarian cells (figures 3C and 3D).
Densitometric analysis of the immune signal revealed that
after 24 hour incubation, NGF induced an increase in
VEGF staining in neonatal rat ovaries, which was signifi-
cant both for the overall staining of the ovarian tissue and
for staining of primary follicles (figure 3F). No significant
differences in VEGF staining were found in shorter incu-
bations (2, 4 or 8 h). As to TGFβ1, a specific mark was
detected in oocytes (figure 4A and 4B). The same as for
mRNA, H-Score of TGFβ1 immunoreactivity was not
modified by NGF (figure 4D).
Denervation of the ovary increases VEGF 
immunoreactivity in prepubertal rats
It was important to determine whether this neurotrophin
would increase VEGF in an in vivo condition previously
informed to provoke an increase in NGF in the rat ovary.
We performed a superior ovarian nerve (SON) sectioning
in prepubertal rats and confirmed that NGF protein levels,
evaluated by densitometry of immunohistochemistry-
processed tissues, were increased in theca cell layers of
ovaries obtained from denervated animals when com-
pared to control ones (figure 5). Nevertheless, after 6 days
of denervation, no change was found in mRNA level of
VEGF and TGFβ1 (figure 6). Although there were no dif-
ferences in mRNA content, H-Score evaluation indicated
that the immunoreactivity for VEGF was significantly
increased in the inner granulosa cell layer of denervated
ovaries as compared with control animals (Figure 7A,B
and 7D). TGFβ1 immunoreactivity did not change after
denervation (results not shown). To evaluate if there was
an earlier change in VEGF and TGFβ1 mRNA levels or in
TGFβ1 protein, the same studies were performed on day 3
of SON sectioning. We found no significant difference for
any of the markers studied (results not shown).
Denervation of the ovary increases blood vessels area in 
prepubertal rats
We wanted to evaluate if denervated rats, which have
higher ovarian NGF levels, present an increase in ovarian
blood vessels. Immunohistochemical studies revealed
that the amount of ovarian small vessels and capillaries,
evaluated as % area of PECAM-1 positive staining was
increased in rats denervated for 6 days, when compared to
control animals (figure 8A-D and 8G). A similar result was
found in denervated animals as early as three days after
SON sectioning (figure 8F).
Discussion
The present study shows that NGF increased the expres-
sion of the angiogenic factor VEGF and the area of blood
vessels detected by the endothelial cell marker PECAM-1,
making a connection between two essential processes in
ovarian physiology, such as angiogenesis and ovulation.
There is an increase of both NGF and its receptor trkA a
few hours before ovulation in the rat ovary; this seems to
be a critical step in the ovulatory cascade, since the use of
a neutralizing antibody to NGF or a blocker of trkA activ-
ity inhibits the ovulation [19]. In this periovulatory time
and specially following ovulatory rupture, there is period
of intensive follicular/luteal vascularization, in which
angiogenic growth factors such as VEGF, essential for
Table 1: Primer sequences used for PCR of cDNAs
Gene Forward and reverse primers (5'– 3') PCR product size (bp) Reference
VEGF F: GCCAGCACATAGGAGAGATGAG
R: ACCGCCTTGGCTTGTCAC
234, 102 Adapted from [45]
TGFβ1 F: AAGTGGATCCACGAGCCCAA
R: GCTGCACTTGCAGGAGCGCA
246 [46]
Cyclophilin F: CTTTGCAGACGCCGCTGTCTCTTTTCGCCG
R: GCATTTGCCATGGACAAGATGCCAGGA
350 [47]Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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endothelial cell proliferation, become highly expressed
[1,7].
Finding VEGF expression in the neonatal ovary suggests
that VEGF could also have actions different from neovas-
cularization in early stages of ovarian development (e.g.
proliferation of somatic cells or increased vessel permea-
bility to allow extravasation of nutrients and hormones).
NGF induced an early VEGF mRNA increase in neonatal
rat ovaries. The explanation of this rapid response could
lie on the presence of trkA in the rat ovary shortly after
birth [32]. Indeed, NGF has been found necessary not
only during the ovulatory process: ovaries from NGF-null
mutant mice have a reduced population of primary and
secondary follicles, a higher number of oocytes that are
not incorporated into follicles, and a reduction in cell pro-
PCR products for the cDNAs evaluated in this study Figure 1
PCR products for the cDNAs evaluated in this study. Pannels A, B and C show photographs of agarose electrophoresis 
for representative PCR products of the different target sequences studied: Pannel A shows PCR products for VEGF (102 bp 
for VEGF 120 and 234 bp for VEGF 164) of control samples (C) and NGF treated ovaries (N); additional bands corresponding 
to other VEGF isoforms were also visible for some samples and thus could not be considered in this study. Pannel B shows 
PCR product for TGFβ1 (246 bp) of control (C) and NGF treatment (N); Pannel C shows PCR products for the constitutive 
gene Cyclophilin (350 bp) of control (C) and NGF treatment (N). Negative controls in each photograph correspond to the 
lane indicated as (-). Pannels D, E and F represent graphs of PCR reactions starting with different quantities of cDNA, indicating 
the linear range in which each densitometry was made in order to observe differences in each experimental condition: D) Lin-
ear range for VEGF amplification (r2 = 0.9936 for VEGF 120 and r2 = 0.9863 for VEGF 164); E) Linear range for TGFβ1 amplifi-
cation (r2 = 0.9996); F) Linear range for Cyclophilin amplification (r2 = 0.9988). Each graph represents PCR products obtained 
from a pool of cDNA samples.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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liferation. [33]. Immunoneutralization of NGF during
early postnatal life of the rat impairs the growth of antral
follicles and delays puberty [18]. In this respect, the NGF/
trkA complex may act as a regulator of ovarian VEGF
expression in the first days of postnatal life of the rat.
This study shows that NGF can increase two mayor angio-
genesis-related parameters within the ovary: 1) the expres-
sion of VEGF, an ovarian pro-angiogenic molecule, and 2)
the amount of ovarian blood vessels. It remains to be elu-
cidated if the increase in blood vessels is a consequence of
NGF binding to trkA receptor in endothelial cells, or is
mediated by the increase of VEGF, but it is reported that
NGF is able to activate endothelial cell proliferation inde-
pendent of VEGF [34]. VEGF 120 and VEGF 164 mRNAs
did not change after three or six days of SON denervation,
a result that could be explained by the early response of
neonatal ovaries exposed to NGF.
NGF did not modify TGFβ1 expression, either in neonatal
or in prepubertal rat ovaries. This, in addition to previ-
ously informed data in the hamster ovary that the expres-
sion of TGFβ receptors mRNA changed cyclically [13],
suggest that TGFβ1 action on ovarian cycle might be con-
trolled at TGFβ receptor expression rather than ligand
level. On the other hand, it is known that NGF is able to
modulate the expression of TGFβ receptors in grafted
adrenal chromaffin cells, by reducing the level of TβRII
mRNA [35]. Then, it would be very interesting to study the
NGF effect on TGFβ receptors expression in the ovary to
better understand this mechanism.
Defects in angiogenesis regulation can be related with a
variety of pathologies, like hemangioma, psoriasis and
most of neoplasic conditions [36-38]. Women suffering
from polycystic ovaries have an increased ovarian blood
flow, which is probably associated with the higher serum
VEGF levels found in these patients [39]. An elevation of
ovarian NGF and p75 is observed in rats with steroid-
induced polycystic ovaries, and the intraovarian adminis-
tration of a neutralizing antiserum to NGF in conjunction
with an antisense to p75 normalized estrous cyclicity and
ovulatory capacity in a majority of the animals [40]. It
cannot be discarded that fertility disorders like polycystic
ovary, or others associated with impaired angiogenesis
have a genesis in a deregulation of NGF expression or
function that results in aberrant production of VEGF.
mRNA content of VEGF isoforms and TGFβ1 in neonatal rat ovaries cultured for 2 hours with NGF Figure 2
mRNA content of VEGF isoforms and TGFβ1 in neonatal rat ovaries cultured for 2 hours with NGF. The results 
were evaluated by densitometric analysis of PCR products bands and expressed as arbitrary units (AU, pixels from specific 
gene/pixels from constitutive gene) mean ± SEM from n = 5. * p < 0.05 and ** p < 0.01 vs control.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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VEGF immunostaining in neonatal rat ovaries cultured for 24 hours with NGF Figure 3
VEGF immunostaining in neonatal rat ovaries cultured for 24 hours with NGF. Arrows depict the predominant 
location of VEGF in granulosa cells of the ovarian follicles (A-B). Arrowheads indicate the presence of VEGF in other cell types 
of the tissue (C-D), such as oocytes. A and C show the staining of representative control ovaries, and B and D the respective 
NGF-treated tissues. A negative immunohistochemistry is shown in E. Mean ± SEM for densitometry from n = 5, are shown in 
F. * p < 0.05 vs control. Original magnification 100×. Bar = 50 μm.
TGFβ1 immunostaining in neonatal rat ovaries cultured for 24 hours with NGF Figure 4
TGFβ1 immunostaining in neonatal rat ovaries cultured for 24 hours with NGF. Arrows depict the predominant 
location of TGFβ1 at the oocytes. A and B show the staining of control and NGF-treated ovaries, respectively. A negative 
immunohistochemistry is shown in C. Mean ± SEM for H-Score from n = 5 are shown in D. Original magnification 100×. Bar = 
50 μm.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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Finally, our group has demonstrated that VEGF is regu-
lated by NGF in epithelial ovarian cancer [41].
Accumulating evidence about the importance of the neu-
rotrophins and their receptors in ovarian physiology has
mRNA content of VEGF isoforms and TGFβ1 in rats with increased ovarian NGF induced by SON dissection Figure 6
mRNA content of VEGF isoforms and TGFβ1 in rats with increased ovarian NGF induced by SON dissection. 
The results were evaluated by densitometric analysis of PCR products bands and expressed as arbitrary units (AU, pixels from 
specific gene/pixels from constitutive gene) mean ± SEM from n = 5.
NGF immunostaining in rats with a dissection of the superior ovarian nerve (SON) Figure 5
NGF immunostaining in rats with a dissection of the superior ovarian nerve (SON). Positive reaction was evalu-
ated by densitometry and results were expressed as mean ± SEM from n = 5. * p < 0.05 vs control.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
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appeared [14-16]. In addition to NGF, also BDNF, NT3
and NT4 have been described in the neonatal ovary
[32,42] and some of them have been associated with early
follicular development [32]. NGF and trkA have been
involved in processes such as steroidogenesis, FSH recep-
tor expression and proliferation of somatic cells in rodent
and human ovary [17,43,44]. Our results are the first to
relate NGF with ovarian angiogenesis and confirm the
angiogenic effects of NGF in the rat ovary, giving new
insight for a role of NGF in the mammalian ovarian func-
tion.
Conclusion
PCR and immunohistochemistry studies showed that
NGF can increase VEGF expression in cultured neonatal
rat ovaries. This was verified in an in vivo model: prepuber-
tal rats with a dissection of the superior ovarian nerve –
performed to increase the local levels of NGF – had also
increased VEGF immunoreactivity within the ovary on the
day six after denervation. TGFβ1 expression was not mod-
ified by NGF in any of the models under study.
In prepubertal rats NGF is able to increase the area of ovar-
ian vessels, as shown by endothelial cell staining. The %
area of PECAM-1 positive staining was increased in rats
denervated for 3 and 6 days, when compared to control
animals.
In summary, the present study shows that NGF increases
the expression of the angiogenic factor VEGF and the area
of blood vessels in the rat ovary, two major events of the
periovulatory period that are fundamental for ovarian
physiology.
Competing interests
The author(s) declare that they have no competing inter-
ests.
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in D. * p < 0.05 vs control. Original magnification 40×. Bar = 150 μm.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
Page 10 of 11
(page number not for citation purposes)
Authors' contributions
MJ-P carried out the experimental design, performed the
tissue cultures, immunohistochemistries and PCR studies,
statistical analysis, interpretation of data and drafted the
manuscript. HEL performed the rat surgeries and contrib-
uted to draft the manuscript. JAB helped with the rat sur-
geries and contributed to the data analysis and to draft the
manuscript. CR participated in the design and coordina-
tion of the study, contributed to the data analysis and
helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We thank Dr. Ximena Campos for critical comments and Prof. Claudio 
Telha for manuscript reviewing. This research was supported by grants 
Fondo Nacional de Desarrollo Científico y Tecnológico #1030661 (CR), 
Comisión Nacional de Investigación Científica y Tecnológica #4040059 and 
Departamento de Postgrado y Postítulo Universidad de Chile #PG/90/2003 
and #PG/67/2005 (MJ-P). MJ-P and JAB are PhD students of the Biochem-
istry Postgraduate Program of Universidad de Chile, supported by scholar-
ships from the Comisión Nacional de Investigación Científica y Tecnológica 
(Conicyt #102241 and 102240, respectively).
References
1. Fraser HM, Wulff C: Angiogenesis in the primate ovary.  Reprod
Fertil Dev 2001, 13:557-566.
2. Mattioli M, Barboni B, Turriani M, Galeati G, Zannoni A, Castellani G,
Berardinelli , Scapolo PE: Follicle activation involves vascular
endothelial growth factor production and increased blood
vessel extension.  Biol Reprod 2001, 65:1014-1019.
3. Ferrara N: Role of vascular endothelial growth factor in regu-
lation of physiological angiogenesis.  Am J Physiol Cell Physiol 2001,
280:C1358-C1366.
4. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM: Prevention of
thecal angiogenesis, antral follicular growth, and ovulation in
the primate by treatment with vascular endothelial growth
factor trap R1R2.  Endocrinology 2002, 143:2797-2807.
5. Geva E, Jaffe RB: Role of vascular endothelial growth factor in
ovarian physiology and pathology.  Fertil Steril 2000, 74:429-438.
PECAM-1 immunostaining in rats with increased ovarian NGF as a consequence of SON dissection Figure 8
PECAM-1 immunostaining in rats with increased ovarian NGF as a consequence of SON dissection. Arrows 
depict the predominant location of vessels in the area surrounding the ovarian follicles. Small vessels are depicted by arrow-
heads. A-B show the immunostaining found in control rat ovaries, and C-D show the ovaries of 6-day denervated rats, where 
a bigger area of capillaries and small vessels was stained. F and G show the quantification of the stained vessels area in rats den-
ervated for 3 (n = 3) and 6 days (n = 5), respectively. The area of vessels positively stained was evaluated with the Image-J pro-
gram and results were expressed as mean ± SEM. * p < 0.05 and ** p < 0.01 vs control. Original magnification 100×. Bar = 100 
μm.Reproductive Biology and Endocrinology 2006, 4:57 http://www.rbej.com/content/4/1/57
Page 11 of 11
(page number not for citation purposes)
6. Philips HS, Hains J, Leung DW, Ferrara N: Vascular endothelial
growth factor is expressed in rat corpus luteum.  Endocrinology
1990, 127:965-967.
7. Koos RD: Increased expression of vascular endothelial
growth/permeability factor in the rat ovary following an ovu-
latory gonadotropins stimulus.  Biol Reprod 1995, 52:1426-1435.
8. Pepper MS: Transforming growth factor-beta: vasculogenesis,
angiogenesis, and vessel wall integrity.  Cytokine Growth Factor
Rev 1997, 8:21-43.
9. Papetti M, Herman IM: Mechanisms of normal and tumor-
derived angiogenesis.  Am J Physiol Cell Physiol 2002,
282:C947-C970.
10. Chegini N, Flanders KC: Presence of transforming growth fac-
tor-β and their selective cellular localization in human ovar-
ian tissue of various reproductive stages.  Endocrinology 1992,
130:1707-1715.
11. Chegini N, Williams RS: Immunocytochemical localization of
transforming growth factors (TGFs) TGF-α and TGF-β in
human ovarian tissues.  J Clin Endocrinol Metab 1992, 74:973-980.
12. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Eth-
ier JF: Recruitment and development of the follicle; the roles
of the transforming growth factor-β superfamily.  Mol Cell
Endocrinol 2002, 191:35-43.
13. Roy SK: Regulation of transforming growth factor-β-receptor
type I and type II messenger ribonucleic acid expression in
the hamster ovary by gonadotropins and steroid hormones.
Biol Reprod 2000, 62:1858-1865.
14. Mattioli M, Barboni B, Gioia L, Lucidi P: Nerve growth factor pro-
duction in sheep antral follicles.  Domest Anim Endocrinol 1999,
17:361-371.
15. Ren L, Medan MS, Weng Q, Jin W, Li C, Watanabe G, Taya K: Immu-
nolocalization of nerve growth factor (NGF) and its recep-
tors (trkA and p75LNGFR) in the reproductive organs of
Shiba goats.  J Reprod Dev 2005, 51:399-404.
16. Levanti MB, Germana A, Abbate F, Montalbano G, Vega JA, Germana
G: TrkA and p75NTR in the ovary of adult cow and pig.  J Anat
2005, 207:93-96.
17. Romero C, Paredes A, Dissen GA, Ojeda SR: Nerve growth factor
induces the expression of functional FSH receptors in newly
formed follicles of the rat ovary.  Endocrinology 2002,
143:1485-1494.
18. Lara HE, McDonald JK, Ojeda SR: Involvement of nerve growth
factor in female sexual development.  Endocrinology 1990,
126:364-375.
19. Dissen GA, Hill DF, Costa ME, Les Dees CW, Lara HE, Ojeda SR: A
role for trkA nerve growth factor receptors in mammalian
ovulation.  Endocrinology 1996, 137:198-209.
20. Chiaretti A, Piastra M, Caresta E, Nanni L, Aloe L: Improving
ischaemic skin revascularisation by nerve growth factor in a
child with crush syndrome.  Arch Dis Child 2002, 87:446-448.
21. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P: Nerve
growth factor promotes angiogenesis and arteriogenesis in
ischemic hindlimbs.  Circulation 2002, 106:2257-2262.
22. Seo K, Choi J, Park M, Rhee C: Angiogenesis effects of nerve
growth factor (NGF) on rat corneas.  J Vet Sci 2001, 2:125-130.
23. Manni L, Antonelli A, Costa N, Aloe L: Stress alters vascular
endothelial growth factor expression in rat arteries: Role of
nerve growth factor.  Basic Res Cardiol 2005, 100:121-130.
2 4 . W a n g  T ,  H o r n g  S ,  C h a n g  C ,  W u  H ,  T s a i  Y ,  W a n g  H ,  S o o n g  Y :
Human chorionic gonadotropin-induced ovarian hyperstim-
ulation syndrome is associated with up-regulation of vascu-
lar endothelial growth factor.  J Clin Endocrinol Metab 2002,
87:3300-3308.
25. Laitinen M, Ristimäki A, Honkasalo M, Narko K, Paavonen K, Ritvos
O: Differential hormonal regulation of vascular endothelial
growth factors VEGF, VEGF-B, and VEGF-C messenger
ribonucleic acid levels in cultured human granulosa-luteal
cells.  Endocrinology 1997, 138:4748-4756.
26. Dissen GA, Lara HE, Fahrenbach WH, Costa ME, Ojeda SR: Imma-
ture rat ovaries become revascularized rapidly after
autotransplantation and show a gonadotropin-dependent
increase in angiogenic factor gene expression.  Endocrinology
1994, 134:1146-1154.
27. McGee EA, Hsueh AW: Initial and cyclic recruitment of ovarian
follicles.  Endocrine Rev 2000, 21:200-214.
28. George FW, Ojeda SR: Vasoactive intestinal peptide enhances
aromatase activity in the neonatal rat ovary before develop-
ment of primary follicles or responsiveness to follicle-stimu-
lating hormone.  Proc Natl Acad Sci USA 1987, 84:5803-5807.
29. Lara HE, Hill DF, Katz KH, Ojeda SR: The gene encoding nerve
growth factor is expressed in the immature rat ovary: effect
of denervation and hormonal treatment.  Endocrinology 1990,
126:357-363.
30. Gerendai I, Marchetti B, Maugeri S, Roxas MA, Scapagnini U: Preven-
tion of compensatory ovarian hypertrophy by local treat-
ment of the ovary with 6-OHDA.  Neuroendocrinology 1978,
27:272-278.
31. Anaf V, Simon P, El Nakadi I, Fayt I, Simonart T, Buxant F, Noel JC:
Hyperalgesia, nerve infiltration and nerve growth factor
expression in deep adenomyotic nodules, peritoneal and
ovarian endometriosis.  Hum Reprod 2002, 17:1895-1900.
32. Dissen GA, Hirshfield AN, Malamed S, Ojeda SR: Expression of
Neurotrophins and their receptors in the mammalian ovary
is developmentally regulated: changes at the time of follicu-
logenesis.  Endocrinology 1995, 136:4681-4692.
33. Dissen GA, Romero C, Newman Hirshfield A, Ojeda SR: Nerve
growth factor is required for early follicular development in
the mammalian ovary.  Endocrinology 2001, 142:2078-2086.
34. Cantarella G, Lempereur L, Presta M Ribatti R, Lombardo G, Lazaro-
vici P, Zappala G, Pafumi C, Bernardini R: Nerve growth factor-
endothelial cell interaction leads to angiogenesis in vitro and
in vivo.  FASEB J 2002, 16:1307-1309.
35. Förander P, Krieglstein K, Söderström S, Strömberg I: Mutual
induction of TGFβ1 and NGF after treatment with NGF or
TGFβ1 in grafted chromaffin cells of the adrenal medulla.
Exp Neurol 2000, 164:303-313.
36. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J: Endothelial progeni-
tor cells in infantile hemangioma.  Blood 2004, 103:1373-1375.
37. Veale DJ, Ritchlin C, FitzGerald O: Immunopathology of psoriasis
and psoriatic arthritis.  Ann Rheum Dis 2005, 64:26-29.
38. Ferrara N, Davys-Smith T: The biology of vascular endothelial
growth factor.  Endocrine Rev 1997, 18:4-25.
39. Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis
J, Tan SL, Campbell S, Jacobs HS: Serum vascular endothelial
growth factor concentrations and ovarian stromal flow are
increased in women with polycystic ovaries.  Hum Reprod 1998,
13:651-655.
40. Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Fiedler JL,
Ojeda SR: An increased intraovarian synthesis of nerve
growth factor and its low affinity receptor is a principal com-
ponent of steroid-induced polycystic ovary in the rat.  Endo-
crinology 2000, 141:1059-1072.
41. Campos X, Munoz Y, Selman A, Yazig i R, Moyano L, Weinstein-
Oppenheimer C, Lara HE, Romero C: Nerve growth factor and
its high-affinity receptor trkA participate in the control of
vascular endothelial growth factor expression in epithelial
ovarian cancer.  Gynecol Oncol  in press. 2006, Aug 24
42. Anderson RA, Robinson LL, Brooks J, Spears N: Neurotropins and
Their Receptors Are Expressed in the Human Fetal Ovary.  J
Clin Endocrinol Metab 2002, 87:890-897.
43. Abir R, Fisch B, Jin S, Barnnet M, Ben-Haroush A, Felz C, Kessler-Icek-
son G, Feldberg D, Nitke S, Ao A: Presence of NGF and its recep-
tors in ovaries from human fetuses and adults.  Mol Hum
Reprod 2005, 11:229-236.
44. Salas C, Julio-Pieper M, Valladares M, Pommer R, Vega M, Mastronardi
C, Kerr B, Ojeda SR, Lara HE, Romero C: Nerve growth factor-
dependent activation of trkA receptors in the human ovary
results in synthesis of FSH receptors and estrogen secretion.
J Clin Endocrinol Metab 2006, 91:2396-2403.
45. Zhang L, Yang N, Conejo Garcia JR, Mohamed A, Benencia F, Rubin
SC, Allman D, Coukos G: Generation of a syngeneic mouse
model to study the effects of vascular endothelial growth fac-
tor in ovarian carcinoma.  Am J Pathol 2002, 161:2295-2309.
46. Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK,
Härkönen P: Estrogen enhances differentiation of osteoblasts
in mice bone marrow culture.  Bone 1998, 22:201-209.
47. Dissen GA, Parrott JA, Skinner MK, Hill DF, Costa ME, Ojeda SR:
Direct effects of nerve growth factor on thecal cells from
antral ovarian follicles.  Endocrinology 2000, 141:4736-4750.